ClinicalTrials.gov
public full text
Public Domain
A Study to Evaluate the Efficacy, Safety and Tolerability of Oral AK0901 in Children With ADHD
This study is a Phase 3, multicenter, dose-optimized, double-blind, randomized, placebo-controlled study designed to evaluate the efficacy, safety, and tolerability of oral AK0901 capsules in children 6 to 12 years old with Attention Deficit Hyperactivity Disorder（ADHD）.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Long-Term Study on Safety of JNS001 in Adults With Attention-Deficit Hyperactivity Disorder#806800
- Near Infrared Spectroscopy Neurofeedback Training for ADHD#899662
- Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Children With ADHD#892506
- Classroom Study of SPN-812 in Children With ADHD#869226
- Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-315#811136
Record · ID 914684
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive